推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Management and Research 期刊收藏夹

欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此反馈;如有合作推广需求,请点此洽谈

按期刊名首写字母查看 CANCER MANAG RE最新评论:不接受病例报告类的文章 (2025-04-17)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
Springer Nature特刊征稿
已发表SCI?是时候来Springer出书了!
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Cancer Management and Research期刊基本信息Hello,您是该期刊的第156572位访客

基本信息 登录收藏
期刊名字Cancer Management and ResearchCancer Management and Research

CANCER MANAG RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.3
53人评分
我要评分

声誉
6.9

影响力
5.0

速度
9.3

期刊ISSN1179-1322
蝌蝌APP,让您与同行交流更轻松
立即下载
2024-2025最新影响因子
(数据来源于搜索引擎)
2.6 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:2.592
2024-2025自引率0.00%点击查看自引率趋势图
五年影响因子2.6
JCI期刊引文指标 0.52
h-index 32
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
6.400.7090.738
学科分区排名百分位
大类:Medicine
小类:Oncology
Q1100 / 415

期刊简介
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:

◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.
期刊官方网站https://www.dovepress.com/cancer-management-and-research-journal
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
 
期刊投稿网址https://www.dovepress.com/submit_step_1.php
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Management and Research的语言要求,还能让Cancer Management and Research编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Management and Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(8篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2990; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:epidemiology、cancer、anticancer agents、cancer screening、palliative care
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
出版商Dove Medical Press Ltd.
涉及的研究方向Medicine-Oncology
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 147点击查看年文章数趋势图
Gold OA文章占比99.63%
研究类文章占比:
文章 ÷(文章 + 综述)
81.63%
WOS期刊JCR分区
2024-2025年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ3181/326
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ3205/326
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:预警等级:中

2020年12月发布的2020版:不在预警名单中
中国科学院期刊分区
2025年3月最新升级版
点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
ONCOLOGY
肿瘤学
1区2区4区
中国科学院期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区2区
ONCOLOGY
肿瘤学
3区4区4区
中国科学院期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区4区
ONCOLOGY
肿瘤学
3区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1322%5BISSN%5D
平均审稿速度网友分享经验:
16 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( USD2990; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Management and Research顺利发表。
快看看作者怎么说吧:服务好评(1篇) 论文致谢(8篇)
提交文稿
期刊常用信息链接
同领域相关期刊 Cancer Management and Research期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Management and Research中国科学院期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Management and Research上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Nature Cancer034.20
    JAMA Oncology4132.60
    JAMA Oncology6132.60
    Trends in Cancer025.50
    Experimental Hematology & Oncology014.30
    Liver Cancer2519.50
    Cancer Biology & Medicine299.60
    ESMO Open012.40
    Annual Review of Cancer Biology06.60
    Cancers538.80
    中国科学院期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE761175
    BIOMATERIALS625331
    BIOMEDICINE & PHARMACOTHERAPY619702
    JOURNAL OF ETHNOPHARMACOLOGY608717
    COMPUTERS IN BIOLOGY AND MEDICINE598729
    Frontiers in Pharmacology589565
    Frontiers in Immunology581893
    Frontiers in Oncology520478
    PHYTOMEDICINE493915
    COLLOIDS AND SURFACES B-BIOINTERFACES478465
  •  

    Cancer Management and Research Cancer Management and Research
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery

    Author: Xu, Xue-Lian; Cheng, Hao; Wu, Xin-Meng; Xu, Jin-Hong
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 985-996. DOI: 10.2147/CMAR.S527496
        PubMed      DOI
    2.Expression and Diagnostic Value of Nrf2 and p62 in Cervical Squamous Cell Carcinoma and Intraepithelial Lesions

    Author: Wei, Wei; Hu, Xingyan; Han, Qing
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1005-1013. DOI: 10.2147/CMAR.S513226
        PubMed      DOI
    3.Risk Factors and Prognostic Implications in Synchronous Breast-Thyroid Dual Primary Cancers: A Matched Case-Control Study

    Author: Li, Tao; Lu, Bin; Zhang, Yantao; Zhang, Peng; Qi, Jun; Sun, Yong
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 997-1004. DOI: 10.2147/CMAR.S505310
        PubMed      DOI
    4.A Comprehensive Study of Part-Solid Lung Adenocarcinoma with Lymph Node Metastasis: Clinical, Pathological, and Radiological Perspectives

    Author: Zhao, Ziya; Gan, Hui; Fu, Bin-jie; Li, Wangjia; Lv, Fajin; Chu, Zhigang
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1015-1027. DOI: 10.2147/CMAR.S520781
        PubMed      DOI
    5.Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients

    Author: Ni, Wenjie; Wang, Xiunan; Wang, Qin; Ge, Yongqing; Mu, Xiaofeng
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1047-1058. DOI: 10.2147/CMAR.S522807
        PubMed      DOI
    6.Long Non-Coding RNA TPTEP1 Exerts Tumor Suppressive Functions via Sequestering miR-4295 to Regulate Growth Arrest and DNA Damage-Inducible 45α Expression in Acute Myeloid Leukemia

    Author: Liu, Xueni; Gui, Yonghui; Wang, Chao; Xia, Kang; Yang, Peng
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1059-1072. DOI: 10.2147/CMAR.S486875
        PubMed      DOI
    7.Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLC

    Author: Liu, Jingyi; Xie, Mei; Shen, Jing; Yao, Jie; Lin, Xuwen; Bao, Xinyu; Zhang, Xin; Liang, Yiran; Yang, Yun; Jiang, Gege; Diao, Ximeng; Han, Wenya; Du, Hai; Xue, Xinying; Wu, Jianlin
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1073-1086. DOI: 10.2147/CMAR.S522136
        PubMed      DOI
    8.Integrating Machine Learning Algorithms to Construct a Triaptosis-Related Prognostic Model in Melanoma

    Author: Xie, Jiaheng; Zhang, Min; Qi, Min
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1127-1141. DOI: 10.2147/CMAR.S525738
        PubMed      DOI
    9.Associations Between Postoperative Symptom Clusters and Functional Status in Lung Cancer Patients: A Cross-Sectional Study

    Author: Liu, Yali; Lin, Siya; Bai, Meirong; Yi, Huochun
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1099-1111. DOI: 10.2147/CMAR.S507420
        PubMed      DOI
    10.Jujuboside B Inhibits the Proliferation and Migration of Non-Small Cell Lung Cancer H1299 Cells Through Inhibiting PI3K/Akt and Wnt/β-Catenin Pathways

    Author: Chen, Mengzhu; Li, Jian; Hu, Shaodan; Wang, Yuhan; Wang, Keju; Wang, Tan
    Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1143-1153. DOI: 10.2147/CMAR.S526130
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    Corrosion Communications013.60
    Water Cycle09.60
    Journal of Road Engineering010.30
    Ukrainian Journal of Physical Optics1412.30
    Integrated Environmental Assessment and Management486.90
    Progress of Theoretical and Experimental Physics3110.40
    Journal of Obesity & Metabolic Syndrome011.10
    HARVARD BUSINESS REVIEW01.80
    PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF THE PACIFIC1367.90
    Pulse00.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共1076


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室